Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevenar Special Use-result Surveillance (Multi-center, Prospective Observational Safety Surveillance For Prevenar In Japan)

NCT01521897 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT01521897
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01521897 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevenar Special Use-result Surveillance (Multi-center, Prospective Observational Safety Surveillance For Prevenar In Japan)
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
September 30, 2010
Completion date
April 30, 2015
Enrollment
1,143 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pneumococcal vaccine, streptococcus pneumoniae